IP

Business Context and Reporting Period

Company: International Paper Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Context: The quarter was characterized by a difficult business environment with lower average prices for paper and packaging products compared to prior periods. However, results were supported by higher sales volumes, improved mill operating performance, and cost reduction initiatives. A significant event was the agreement to sell the Carter Holt Harvey tissue business, which is now classified as a discontinued operation.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 6.4% year-over-year to $6.36 billion, driven primarily by higher sales volumes across all segments.
• Profitability: Net earnings increased 66% to $73 million. Earnings from continuing operations rose to $70 million from $51 million.
• Price vs. Volume: While volume contributed positively ($30 million impact), lower average price realizations negatively impacted earnings by approximately $40 million. High wood fiber and energy costs also reduced margins by $16 million.
• Restructuring: Restructuring and other charges were $30 million in Q1 2004 compared to $23 million in Q1 2003. This included $16 million for losses on early extinguishment of debt.
• Discontinued Operations: The Carter Holt Harvey tissue business results are now excluded from continuing operations, with a $3 million net earnings contribution from discontinued operations.

Guidance, Outlook, and Risks

Management Commentary and Outlook

• Second Quarter Expectations: Management anticipates stronger operating results in Q2 2004 due to announced price increases in industrial packaging, uncoated free sheet, coated papers, and pulp. Demand is expected to continue improving.
• Cost Initiatives: The company continues to focus on cost reduction, including a program targeting a reduction of 3,000 salaried positions by late 2004. To date, $75 million in severance costs has been recorded.
• Capital Spending: Full-year 2004 capital spending is projected at approximately $1.3 billion, which is below projected depreciation and amortization charges.

Risks and Contingencies

• Legal Proceedings: Significant litigation includes a class action regarding fiber procurement prices (certified March 2004), a price-fixing settlement for corrugated sheets ($24.4 million share), and a high-pressure laminate settlement ($31 million federal + $3.5 million state). A reserve of $352 million remains for exterior siding and roofing lawsuits.
• Market Risks: Exposure to fluctuations in raw material costs (wood fiber, energy), foreign currency exchange rates (particularly the New Zealand dollar and Euro), and general economic conditions.
• Debt Refinancing: The company actively manages debt, recently issuing $1 billion in new notes to retire higher-coupon debt. Moody's changed the outlook to "negative" in late April 2004.

Investor Verification Checklist

• Discontinued Operation Gain: Verify the realization of the estimated $140-$150 million pretax gain from the sale of the Carter Holt Harvey tissue business upon closing.
• Price Realization: Monitor whether announced price increases in Q2 2004 are successfully passed through to customers to offset high input costs.
• Restructuring Costs: Track additional severance charges expected in Q2 and Q3 2004 related to the 3,000 position reduction program.
• Legal Reserves: Review updates on the $352 million reserve for Masonite siding/roofing litigation and the status of the $68 million corrugated price-fixing settlement approval.
• Debt Structure: Confirm the impact of the new credit facilities and debt issuances on interest expense and liquidity ratios.